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Vitiligo in the FAS lane
A combination of 
environmental, genetic, 
and immunologic factors 
underlies vitiligo, a disease 
accompanied by autoimmune 
melanocyte destruction. 
FAS and FASLG participate 
in regulating apoptosis 
in T lymphocytes, and 
polymorphisms in these genes 
have been associated with 
increased risk of autoimmune 
diseases. Li and colleagues 
found an increased risk 
of vitiligo associated with 
certain FAS-1377 alleles, 
as well as with genotypes 
with multiple risk alleles. 
The authors suggest that 
defective FAS function 
may slow cell apoptosis or 
facilitate autoimmunity via 
release of apoptosis-related 
antigens.  See page 2820
Depleting B Cells
Rituximab has proven useful 
in treating B-cell cancers and 
autoimmune diseases. Mouquet 
and colleagues found that 
rituximab treatment induced 
depletion of peripheral B cells, 
with a subsequent decrease in 
serum IgM levels in pemphigus 
patients. Importantly, rituximab 
decreased the level of 
autoantibodies directed against 
desmogleins, the desmosomal 
transmembrane glycoproteins 
pathologically targeted in 
patients; however, levels of 
antimicrobial antibodies were 
not modified. Thus, relatively 
specific changes in the immune 
responses that underlie the 
therapeutic effects of rituximab 
may explain the long-lasting 
effects of this therapy in 
pemphigus patients.   
See page 2859 
Prenatal Peek
Because no effective therapy is available to treat junc-
tional and simplex epidermolysis bullosa (EB) with 
pyloric atresia (PA-JEB and PA-EBS), prenatal diagnosis 
is critical for expecting parents at risk. Although muta-
tions in integrin α6β4 and plectin have been identified 
in PA-JEB and PA-EBS patients, respectively, prenatal 
DNA analysis is not useful for patients with unidenti-
fied mutations. D’Alessio and colleagues employed 
immuno fluorescence analysis of integrin α6β4 and 
plectin in first-trimester chorionic villi to diagnose 
severe EB prenatally. This innovative method not only 
establishes the phenotype of the fetus but also identifies 
the defective polypeptide, which can then be subjected 
to mutational analysis. See page 2815
Melanoma Trends
Spurred by findings that the incidence of non-melano-
ma skin cancer is increasing in young women in the 
United States, Purdue and colleagues examined mela-
noma rates in Caucasians using data from the National 
Cancer Institute’s Surveillance, Epidemiology, and End 
Results Program from 1973 to 2004. The age-adjust-
ed annual incidence of melanoma increased in young 
men and women. Interestingly, male age-specific inci-
dence increased with each successive birth cohort until 
1950, when it stabilized. Female age-specific incidence 
increased until 1950 and then rose at a slower pace until 
1965, after which it began to accelerate. Clearly, mela-
noma incidence is increasing among young women in 
the United States, and future studies will reveal whether 
changes in UV-exposure habits are primarily to blame. 
See page 2905
Light and Dark
Some genetic studies of pigmenta-
tion in hair and eye color have relied 
on spectrophotometric absorbance to 
measure color. Shekar and colleagues 
probed light–dark hair color using 
spectrophotometric absorbance at 650 
nm to isolate chromosomal regions 
that contained genes affecting hair pig-
mentation. Whereas markers D7S1808 
and D1S235 were linked to hair pig-
mentation, the most significant linkage 
association was with oculocutaneous 
albinism type II (OCA2) on chromosome 15. Indeed, two single-nucleotide poly-
morphisms in this gene (rs4778138 and rs1375164) were associated with darker 
hair color in a semidominant manner. See page 2807
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